Literature DB >> 2535886

Effect of cellular function inhibitors on the infection of Frp/3 cells by hepatitis A virus.

F Superti1, L Seganti, N Orsi, M Divizia, R Gabrieli, A Panà.   

Abstract

The effect of some cellular function inhibitors on hepatitis A virus (HAV) adsorption and on the successive events of infection in a monkey cell line (Frp/3 cells) was investigated. Treatments of Frp/3 cells with colcemide, vinblastine and cytochalasin D, which affect cytoskeleton organization, indicated that neither microtubules nor microfilaments play an important role in the early events of HAV infection. Monensin, which acts as an ionophore on intracellular vesicle compartments inhibited HAV infection probably at the uncoating step. Inhibition of viral replication to a different degree was observed with both inhibitors of oxidative phosphorylation, such as dinitrophenol and sodium azide, and with an inhibitor of glycolysis, 2-deoxy-D-glucose. However, none of these compounds significantly affected the early steps of infection, thus demonstrating that HAV replication is largely dependent upon cell energy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535886     DOI: 10.1007/bf00202289

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  17 in total

1.  Involvement of the microtubule in replication cycles of animal viruses.

Authors:  S Dales
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

2.  Specific visualization of tubulin-containing structures in tissue culture cells by immunofluorescence. Cytoplasmic microtubules, vinblastine-induced paracrystals, and mitotic figures.

Authors:  K Weber; T Bibring; M Osborn
Journal:  Exp Cell Res       Date:  1975-10-01       Impact factor: 3.905

3.  Inhibition of herpes simplex virus type 1 penetration by cytochalasins B and D.

Authors:  K S Rosenthal; R Perez; C Hodnichak
Journal:  J Gen Virol       Date:  1985-07       Impact factor: 3.891

4.  Mechanism of action of cytochalasin B on actin.

Authors:  S MacLean-Fletcher; T D Pollard
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

5.  Is cytoskeleton involved in vesicular stomatitis virus reproduction?

Authors:  N Genty; F Bussereau
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

6.  Studies on the mechanism of influenza virus entry into cells.

Authors:  S Patterson; J S Oxford; R R Dourmashkin
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

7.  Mechanism of rabies virus entry into CER cells.

Authors:  F Superti; M Derer; H Tsiang
Journal:  J Gen Virol       Date:  1984-04       Impact factor: 3.891

8.  Cellular response to rabies virus infection.

Authors:  F Bussereau; P Perrin
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1982       Impact factor: 2.268

9.  Entry of poliovirus type 1 and Mouse Elberfeld (ME) virus into HEp-2 cells: receptor-mediated endocytosis and endosomal or lysosomal uncoating.

Authors:  H Zeichhardt; K Wetz; P Willingmann; K O Habermehl
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891

10.  Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus.

Authors:  K Coombs; E Mann; J Edwards; D T Brown
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

View more
  3 in total

1.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 2.  Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Authors:  Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Masato Nakamura; Xia Jiang; Yuki Haga; Reina Sasaki; Osamu Yokosuka
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

Review 3.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.